BWX Technologies (BWXT) Gets a Hold from Maxim Group

BWX Technologies (BWXT) shares rose 8% after its microreactor design was chosen for Canada's first transportable nuclear plant in Belledune, New Brunswick. The project, led by Prodigy Clean Energy and Indigenous partners, aims to deliver a 50-megawatt facility by the early 2030s. BWXT's BANR reactors will provide electricity and thermal energy, with passive safety systems. The plant will use Ontario's nuclear supply chain for manufacturing.

BWX (NYSE: BWXT) shares rose 7.4% after its BANR microreactor was chosen for a Canadian nuclear power plant project. The plant, supported by provincial intent, aims to generate 50 MW by the early 2030s. BWX is down 19.4% YTD, trading at $146.53, 38.5% below its 52-week high.

BWX Technologies (BWXT) stock rose 7.7% after its BANR microreactor was selected for a project in Canada. Moody’s upgraded its outlook to positive. Analysts' views were mixed. The broader market also gained, with the S&P 500 up 0.9%.

BWX Technologies (BWXT) shares rose 8% after its BANR microreactor was selected for a nuclear power plant project in New Brunswick, Canada. The project, led by Prodigy Clean Energy and First Nations, aims to produce up to 50 MW of electricity by the early 2030s. BWXT will fabricate the reactor units at its Ontario facilities.

Moody’s upgraded BWX Technologies' outlook to positive, citing its strong position in naval nuclear propulsion and stable financials. The company has an $8.4B backlog, 20% EBITDA margin, and $3.5B annual revenue. Moody’s expects BWXT to maintain leverage around 3x debt-to-EBITDA and free cash flow above $200M. A rating upgrade is possible if the company executes its growth strategy.

ARK Innovation ETF, managed by Cathie Wood, bought $81M in Nvidia, $13.1M in Broadcom, and $7.3M in CoreWeave, while selling $111.1M in AMD. Other purchases included Intellia Therapeutics, BWX Technologies, and Tesla. Sales included 10x Genomics, Tempus AI, Alphabet, and Palantir.